What Makes Purdue Pharma's OxyContin Different From Other Opioids?
It seems like Purdue Pharma is taking more heat than other drugmakers for the opioid epidemic, and there's a reason for that.
Purdue Pharma, the maker of the brand-name opioid OxyContin, has been hit with lawsuits from all across the country. The company is accused of downplaying the addictiveness of its drug in an effort to make more money.
But OxyContin isn't the only prescription opioid on the market. So why is Purdue such a frequent target? To try to get at that answer, we'll start with what makes OxyContin different from other prescription opioids.
Doctors have been prescribing opioids for pain since the early 1900s. The opioid drug class includes those made with a variety of active ingredients, including fentanyl, morphine, hydrocodone and oxycodone, which is what OxyContin is made from.
When OxyContin got FDA approval in 1995, it was the first oxycodone drug to come in a time-released formula. That allowed patients to take one pill every 12 hours instead of one pill every four to six hours.
Another differentiating factor is the strength of the active ingredient. In Purdue's drug, oxycodone is the only active ingredient, and its strength ranges from 10-80 mg per pill. Compare that with another brand-name opioid, Percocet: That drug combines oxycodone with acetaminophen, and the maximum strength of the opioid is 10 mg per pill.
Another part of OxyContin's problem is how the drug was abused. People could crush the pills and then snort or inject them. Doing that bypassed the prescription's time-release formula, giving the user a stronger, more immediate high. Purdue eventually acknowledged the problem, and in 2010 it got FDA approval for a reformulated version of OxyContin meant to deter that kind of abuse.
Purdue is currently facing a barrage of lawsuits related to how it marketed OxyContin, but it's not the only opioid maker with that problem. Other drugmakers including Teva Pharmaceuticals and Johnson & Johnson have also been named in recent court cases.
Additional reporting from Newsy affiliate CNN.
California to manufacture its own insulin, cap cost at $30
California has partnered with a manufacturer to produce insulin that is expected to save residents hundreds of dollars every month.
68 injuries, 4 eyeball removals tied to recalled EzriCare eye drops
The CDC said anyone using EzriCare Artificial Tears needs to immediately stop as it investigates the incidents.
Pfizer recalls migraine pill packs due to child safety risk
Pfizer is recalling Nurtec ODT 75 milligram tablets because the products are not in child-resistant packaging.
US, Canada end loophole that let asylum-seekers cross border
Authorities from both sides have been eager to end the process that allowed immigrants to pursue asylum cases without using official crossings.
FAA calls on airlines to help prevent another travel meltdown
The FAA is changing some practices due to recent runway incursion events, and addressing possible effects of staffing shortages.
Why are some citizens protesting in France?
Hundreds of people were arrested in clashes amid some the biggest protests so far against the raising of France's retirement age.